Global Acyclovir Drug Market Insights, Forecast to 2025


Report ID : RC-3130 Category : Pharmaceuticals
Published Date : 2018 Pages : 126 Format : PDF
Acyclovir is used to treat infections caused by herpes viruses.
In 2017, the global Acyclovir Drug market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2018. The objectives of this study are to define, segment, and project the size of the Acyclovir Drug market based on company, product type, application and key regions.

This report studies the global market size of Acyclovir Drug in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Acyclovir Drug in these regions.

This research report categorizes the global Acyclovir Drug market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter's Five Forces Analysis.

The various contributors involved in the value chain of Acyclovir Drug include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in the Acyclovir Drug include

    GSK

    Zydus Pharmaceuticals

    Mylan

    Bausch Health

    Vectans Pharma

    Fresenius Kabi

    Aurobindo Pharma

    Teva

    Heritage Pharmaceuticals

    APOTEX

    Cadila Pharmaceuticals

    Amneal Pharmaceuticals

    TARO

    Glenmark

    G&W Laboratories

    Yiling Pharmaceutical Ltd

    Alembic Pharmaceuticals

Market Size Split by Type

    Oral

    Topical

    Injection

Market Size Split by Application

    Hospital

    Drug store

Market size split by Region

    North America

        United States

        Canada

        Mexico

    Asia-Pacific

        China

        India

        Japan

        South Korea

        Australia

        Indonesia

        Singapore

        Malaysia

        Philippines

        Thailand

        Vietnam

    Europe

        Germany

        France

        UK

        Italy

        Spain

        Russia

    Central & South America

        Brazil

        Rest of Central & South America

    Middle East & Africa

        GCC Countries

        Turkey

        Egypt

        South Africa

The study objectives of this report are:

    To study and analyze the global Acyclovir Drug market size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025.

    To understand the structure of Acyclovir Drug market by identifying its various subsegments.

    To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

    Focuses on the key global Acyclovir Drug manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.

    To analyze the Acyclovir Drug with respect to individual growth trends, future prospects, and their contribution to the total market.

    To project the value and volume of Acyclovir Drug submarkets, with respect to key regions (along with their respective key countries).

    To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

    To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Acyclovir Drug are as follows:

    History Year: 2013-2017

    Base Year: 2017

    Estimated Year: 2018

    Forecast Year 2018 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Acyclovir Drug market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage

    1.1 Acyclovir Drug Product

    1.2 Key Market Segments

    1.3 Key Manufacturers Covered

    1.4 Market by Type

        1.4.1 Global Acyclovir Drug Market Size Growth Rate by Type

        1.4.2 Oral

        1.4.3 Topical

        1.4.4 Injection

    1.5 Market by Application

        1.5.1 Global Acyclovir Drug Market Size Growth Rate by Application

        1.5.2 Hospital

        1.5.3 Drug store

    1.6 Study Objectives

    1.7 Years Considered

2 Executive Summary

    2.1 Global Acyclovir Drug Market Size

        2.1.1 Global Acyclovir Drug Revenue 2016-2025

        2.1.2 Global Acyclovir Drug Sales 2016-2025

    2.2 Acyclovir Drug Growth Rate by Regions

        2.2.1 Global Acyclovir Drug Sales by Regions

        2.2.2 Global Acyclovir Drug Revenue by Regions

3 Breakdown Data by Manufacturers

    3.1 Acyclovir Drug Sales by Manufacturers

        3.1.1 Acyclovir Drug Sales by Manufacturers

        3.1.2 Acyclovir Drug Sales Market Share by Manufacturers

        3.1.3 Global Acyclovir Drug Market Concentration Ratio (CR5 and HHI)

    3.2 Acyclovir Drug Revenue by Manufacturers

        3.2.1 Acyclovir Drug Revenue by Manufacturers (2016-2018)

        3.2.2 Acyclovir Drug Revenue Share by Manufacturers (2016-2018)

    3.3 Acyclovir Drug Price by Manufacturers

    3.4 Acyclovir Drug Manufacturing Base Distribution, Product Types

        3.4.1 Acyclovir Drug Manufacturers Manufacturing Base Distribution, Headquarters

        3.4.2 Manufacturers Acyclovir Drug Product Category

        3.4.3 Date of International Manufacturers Enter into Acyclovir Drug Market

    3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type

    4.1 Global Acyclovir Drug Sales by Type

    4.2 Global Acyclovir Drug Revenue by Type

    4.3 Acyclovir Drug Price by Type

5 Breakdown Data by Application

    5.1 Overview

    5.2 Global Acyclovir Drug Breakdown Data by Application

6 North America

    6.1 North America Acyclovir Drug by Countries

        6.1.1 North America Acyclovir Drug Sales by Countries

        6.1.2 North America Acyclovir Drug Revenue by Countries

        6.1.3 United States

        6.1.4 Canada

        6.1.5 Mexico

    6.2 North America Acyclovir Drug by Type

    6.3 North America Acyclovir Drug by Application

    6.4 North America Acyclovir Drug by Company

7 Europe

    7.1 Europe Acyclovir Drug by Countries

        7.1.1 Europe Acyclovir Drug Sales by Countries

        7.1.2 Europe Acyclovir Drug Revenue by Countries

        7.1.3 Germany

        7.1.4 France

        7.1.5 UK

        7.1.6 Italy

        7.1.7 Russia

    7.2 Europe Acyclovir Drug by Type

    7.3 Europe Acyclovir Drug by Application

    7.4 Europe Acyclovir Drug by Company

8 Asia Pacific

    8.1 Asia Pacific Acyclovir Drug by Countries

        8.1.1 Asia Pacific Acyclovir Drug Sales by Countries

        8.1.2 Asia Pacific Acyclovir Drug Revenue by Countries

        8.1.3 China

        8.1.4 Japan

        8.1.5 Korea

        8.1.6 India

        8.1.7 Australia

        8.1.8 Indonesia

        8.1.9 Malaysia

        8.1.10 Philippines

        8.1.11 Thailand

        8.1.12 Vietnam

        8.1.13 Singapore

    8.2 Asia Pacific Acyclovir Drug by Type

    8.3 Asia Pacific Acyclovir Drug by Application

    8.4 Asia Pacific Acyclovir Drug by Company

9 Central & South America

    9.1 Central & South America Acyclovir Drug by Countries

        9.1.1 Central & South America Acyclovir Drug Sales by Countries

        9.1.2 Central & South America Acyclovir Drug Revenue by Countries

        9.1.3 Brazil

    9.2 Central & South America Acyclovir Drug by Type

    9.3 Central & South America Acyclovir Drug by Application

    9.4 Central & South America Acyclovir Drug by Company

10 Middle East and Africa

    10.1 Middle East and Africa Acyclovir Drug by Countries

        10.1.1 Middle East and Africa Acyclovir Drug Sales by Countries

        10.1.2 Middle East and Africa Acyclovir Drug Revenue by Countries

        10.1.3 GCC Countries

        10.1.4 Turkey

        10.1.5 Egypt

        10.1.6 South Africa

    10.2 Middle East and Africa Acyclovir Drug by Type

    10.3 Middle East and Africa Acyclovir Drug by Application

    10.4 Middle East and Africa Acyclovir Drug by Company

11 Company Profiles

    11.1 GSK

        11.1.1 GSK Company Details

        11.1.2 Company Description

        11.1.3 Sales, Revenue and Gross Margin of Acyclovir Drug

        11.1.4 Acyclovir Drug Product Description

        11.1.5 Recent Development

    11.2 Zydus Pharmaceuticals

        11.2.1 Zydus Pharmaceuticals Company Details

        11.2.2 Company Description

        11.2.3 Sales, Revenue and Gross Margin of Acyclovir Drug

        11.2.4 Acyclovir Drug Product Description

        11.2.5 Recent Development

    11.3 Mylan

        11.3.1 Mylan Company Details

        11.3.2 Company Description

        11.3.3 Sales, Revenue and Gross Margin of Acyclovir Drug

        11.3.4 Acyclovir Drug Product Description

        11.3.5 Recent Development

    11.4 Bausch Health

        11.4.1 Bausch Health Company Details

        11.4.2 Company Description

        11.4.3 Sales, Revenue and Gross Margin of Acyclovir Drug

        11.4.4 Acyclovir Drug Product Description

        11.4.5 Recent Development

    11.5 Vectans Pharma

        11.5.1 Vectans Pharma Company Details

        11.5.2 Company Description

        11.5.3 Sales, Revenue and Gross Margin of Acyclovir Drug

        11.5.4 Acyclovir Drug Product Description

        11.5.5 Recent Development

    11.6 Fresenius Kabi

        11.6.1 Fresenius Kabi Company Details

        11.6.2 Company Description

        11.6.3 Sales, Revenue and Gross Margin of Acyclovir Drug

        11.6.4 Acyclovir Drug Product Description

        11.6.5 Recent Development

    11.7 Aurobindo Pharma

        11.7.1 Aurobindo Pharma Company Details

        11.7.2 Company Description

        11.7.3 Sales, Revenue and Gross Margin of Acyclovir Drug

        11.7.4 Acyclovir Drug Product Description

        11.7.5 Recent Development

    11.8 Teva

        11.8.1 Teva Company Details

        11.8.2 Company Description

        11.8.3 Sales, Revenue and Gross Margin of Acyclovir Drug

        11.8.4 Acyclovir Drug Product Description

        11.8.5 Recent Development

    11.9 Heritage Pharmaceuticals

        11.9.1 Heritage Pharmaceuticals Company Details

        11.9.2 Company Description

        11.9.3 Sales, Revenue and Gross Margin of Acyclovir Drug

        11.9.4 Acyclovir Drug Product Description

        11.9.5 Recent Development

    11.10 APOTEX

        11.10.1 APOTEX Company Details

        11.10.2 Company Description

        11.10.3 Sales, Revenue and Gross Margin of Acyclovir Drug

        11.10.4 Acyclovir Drug Product Description

        11.10.5 Recent Development

    11.11 Cadila Pharmaceuticals

    11.12 Amneal Pharmaceuticals

    11.13 TARO

    11.14 Glenmark

    11.15 G&W Laboratories

    11.16 Yiling Pharmaceutical Ltd

    11.17 Alembic Pharmaceuticals

12 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    12.1 Market Opportunities and Drivers

    12.2 Market Challenges

    12.3 Market Risks/Restraints

    12.4 Key World Economic Indicators

13 Value Chain and Sales Channels Analysis

    13.1 Value Chain Analysis

        13.1.1 Typical Suppliers of Key Acyclovir Drug Raw Material

        13.1.2 Acyclovir Drug Customers

    13.2 Sales Channels Analysis

        13.2.1 Sales Channels Analysis

        13.2.2 Distributors

14 Research Findings and Conclusion

15 Appendix

    15.1 Research Methodology

        15.1.1 Methodology/Research Approach

            15.1.1.1 Research Programs/Design

            15.1.1.2 Market Size Estimation

            15.1.1.3 Market Breakdown and Data Triangulation

        15.1.2 Data Source

            15.1.2.1 Secondary Sources

            15.1.2.2 Primary Sources

    15.2 Author Details

    15.3 Disclaimer

Sidebar Menu